Citations
Mayo Clinic
2819 citation(s) found for "R, Liu".
Factors predicting the use of immunotherapy for patients with advanced melanoma.
Shillington, Alicia C. , Macahilig, Cynthia, Harshaw, Qing, Liu, Frank Xiaoqing, Joseph, Richard W. , Diede, Scott J. , Dave, Vaidehi
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9571-9571
Final results of a phase Ib study of isatuximab (ISA) plus pomalidomide (Pom) and dexamethasone (dex) in relapsed/refractory multiple myeloma (RRMM).
Richardson, Paul G. , Usmani, Saad Zafar, Bensinger, William, Dubin, Franck , Liu, Qianying , Vitse, Olivier , Mıkhael, Joseph , Richardson, Paul Gerard Guy , Usmani, Saad Zafar, Raje, Noopur , Anderson, Kenneth C.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8038-8038
Influence of vitamin D (Vit D) on mammographic density (MD) and insulin like growth factor 1 (IGF1): Results of CALGB (Alliance) 70806.
Wood, Marie , Seisler, Drew K., Ambaye, Abiy B., Le‐Petross, Huong T. , Liu, Heshan , Zekan, Patricia J., Cardinal, Lucien J., Charlamb, Jayne R. , Wang, Lili X, Unzeitig, Gary, Marshall, James R. , Hsieh, Meng-Kang, Kontos, Despina , Jung, Sin‐Ho , Garber, Judy E.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 1549-1549
A randomized phase II study of pembrolizumab, an anti-PD (programmed cell death) 1 antibody, in combination with carboplatin compared to carboplatin alone in breast cancer patients with chest wall disease, with immunologic and genomic correlative studies.
Vidula, Neelima , Goga, Andrei , Hwang, Jimmy , Liu, Minetta C. , Nanda, Rita , Pohlmann, Paula R. , Storniolo, Anna Maria , Brufsky, Adam , Brufsky, Adam M , Park, Ben Ho , Abramson, Vandana G. , Rugo, Hope S. , Pohlmann, Paula
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS1113-TPS1113
TBCRC026: Phase II clinical trial assessing the correlation of standardized uptake value (SUV) on positron emission tomography (PET) with pathological complete response (pCR) to pertuzumab and trastuzumab in patients with primary operable HER2-positive bre
Connolly, Roisín M. , Leal, Jeffrey P. , Sólnes, Lilja B. , Carpenter, Ashley , Gaffney, Katy, Liu, Minetta C. , Rimawi, Mothaffar F. , Specht, Jennifer M. , Storniolo, Anna Maria , Valero, Vicente , Camp, Melissa , Cimino‐Mathews, Ashley , Rimawi, Mothaffar , Specht, Jennifer , Huang, Chiung‐Yu , Gaffney, Katy, Abramson, Vandana G. , Carey, Lisa A. , Vaklavas, Christos , Miller, Robert S. , Wolff, Antonio C. , Wahl, Richard L. , Stearns, Vered
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 511-511
TAPPAS: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma.
Ravi, Vinod , Chawla, Sant P. , Attia, Steven , Riedel, Richard F. , Thornton, Katherine A., Mallick, Atrayee Basu , Liu, Lingyun , Alvarez, Delia, Theuer, Charles P. , Tap, William D. , Jones, Robin L. , Maki, Robert G. , Maki, Robert G , Riedel, Richard F , Jones, Robin L , Brohl, Andrew S. , Liebner, David A. , Mehta, Cyrus R. , Robinson, Steven I. , Penel, Nicolas , Stacchiotti, Silvia
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS11590-TPS11590
ADVL1513: Results of a phase 1 trial of entinostat, an oral histone deacetylase inhibitor, in pediatric patients with recurrent or refractory solid tumors.
Malempati, Suman , Liu, Xiaowei , Fox, Elizabeth , Weigel, Brenda J. , Chang, Bill H , Reid, Joel M. , Minard, Charles G. , Keller, Charles
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 10556-10556
Clinical performance pilot using cognitive computing for clinical trial matching at Mayo Clinic.
Helgeson, J. , Rammage, Melissa, Urman, Alexandra, Roebuck, M. Christopher , Coverdill, Sadie, Pomerleau, K. , Liu, Li‐Ing, Sweetman, Robert, Chau, Quincy, Vinegra, Michael , Haddad, Tufia C. , Dankwa‐Mullan, Irene , Williamson, M Paul, Goetz, Matthew P.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e18598-e18598
A phase 2 biomarker trial of combination cediranib and olaparib in relapsed platinum (plat) sensitive and plat resistant ovarian cancer (ovca).
Barry, William T., Wenham, Robert M. , Hendrickson, Andrea E. Wahner , Armstrong, Deborah K. , Chan, Nancy , Lee, Jung‐Min , Penson, Richard T. , Cristea, Mihaela , Abbruzzese, James L. , Matsuo, Koji , Olawaiye, Alexander , Farooq, Sarah , Kohn, Elise C. , Matulonis, Ursula A. , Liu, Joyce F. , Cohn, David E. , Swisher, Elizabeth M. , Van Allen, Eliezer M , Shapiro, Geoffrey I. , Ivy, S. Percy
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5519-5519
Patterns of PSA versus clinically progressive disease in the E3805 CHAARTED trial.
Liu, Glenn , Jarrard, David F. , García, Jorge A. , Hussain, Maha , Eisenberger, Mario A. , Hahn, Noah M. , DiPaola, Robert S. , Harshman, Lauren C. , Hussain, Maha H A , Bryce, Alan H. , Chen, Yu‐Hui , Carducci, Michael A. , Dreicer, Robert , Kohli, Manish , Plimack, Elizabeth R. , Vogelzang, Nicholas J. , Picus, Joel , Sweeney, Christopher J.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5046-5046